Covered recipient · General Payments record
MELISSA V LAYNE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$805.35
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.16 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $55.24 | 3 |
| PFIZER INC. | $33.58 | 2 |
| Merck Sharp & Dohme Corporation | $20.89 | 1 |
| Seqirus USA Inc | $18.64 | 1 |
| Exact Sciences Corporation | $16.20 | 1 |
| Medtronic, Inc. | $15.54 | 1 |
| Novo Nordisk AS | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Exact Sciences Corporation | $16.20 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114563275 | CMS |
| GlaxoSmithKline, LLC. | $20.30 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116169765 | CMS |
| GlaxoSmithKline, LLC. | $17.44 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116702417 | CMS |
| GlaxoSmithKline, LLC. | $17.50 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116321517 | CMS |
| Medtronic, Inc. | $15.54 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116968837 | CMS |
| Merck Sharp & Dohme LLC | $20.89 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141680805 | CMS |
| Novo Nordisk Inc | $13.07 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100544630 | CMS |
| PFIZER INC. | $14.23 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131250721 | CMS |
| PFIZER INC. | $19.35 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131529737 | CMS |
| Seqirus USA Inc | $18.64 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125628260 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.